Penumbra, Inc. (PEN)
324.54
+0.79
(+0.24%)
USD |
NYSE |
Aug 25, 16:00
324.54
0.00 (0.00%)
After-Hours: 19:59
Penumbra Cash from Operations (Quarterly) : 46.08M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.08M |
| March 31, 2026 | 86.97M |
| December 31, 2025 | 86.48M |
| September 30, 2025 | 58.26M |
| June 30, 2025 | 44.95M |
| March 31, 2025 | 48.97M |
| December 31, 2024 | 51.11M |
| September 30, 2024 | 56.47M |
| June 30, 2024 | 22.61M |
| March 31, 2024 | 38.30M |
| December 31, 2023 | 36.26M |
| September 30, 2023 | 30.84M |
| June 30, 2023 | 17.10M |
| March 31, 2023 | 13.13M |
| December 31, 2022 | 1.337M |
| September 30, 2022 | -12.91M |
| June 30, 2022 | -39.58M |
| March 31, 2022 | -4.514M |
| December 31, 2021 | -9.27M |
| September 30, 2021 | 36.45M |
| June 30, 2021 | -3.31M |
| March 31, 2021 | -14.37M |
| December 31, 2020 | -2.083M |
| September 30, 2020 | -3.55M |
| June 30, 2020 | -21.69M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.92M |
| December 31, 2019 | 4.767M |
| September 30, 2019 | 22.05M |
| June 30, 2019 | 1.903M |
| March 31, 2019 | -2.068M |
| December 31, 2018 | 7.531M |
| September 30, 2018 | 10.44M |
| June 30, 2018 | 0.124M |
| March 31, 2018 | 10.71M |
| December 31, 2017 | -0.907M |
| September 30, 2017 | 10.75M |
| June 30, 2017 | 0.65M |
| March 31, 2017 | 2.194M |
| December 31, 2016 | -10.36M |
| September 30, 2016 | 5.732M |
| June 30, 2016 | -4.598M |
| March 31, 2016 | -3.584M |
| December 31, 2015 | -9.648M |
| September 30, 2015 | -4.30M |
| June 30, 2015 | -5.669M |
| March 31, 2015 | -2.662M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 2.124M |
| March 31, 2014 | -0.132M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp. | 1.474B |
| Globus Medical, Inc. | 209.74M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | 17.45M |
| Teleflex, Inc. | 94.33M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -91.09M |
| Cash from Financing (Quarterly) | 9.025M |
| Free Cash Flow | 215.91M |
| Free Cash Flow Per Share (Quarterly) | 0.8223 |
| Free Cash Flow to Equity (Quarterly) | 36.01M |
| Free Cash Flow to Firm (Quarterly) | 32.78M |
| Free Cash Flow Yield | 1.69% |